https://www.selleckchem.com/products/odm208.html
Intractable serous (not chylous) ascites (IA) that infrequently develops early following pancreaticoduodenectomy (PD) for pancreatic cancer is a life-threatening problem. The relationship between neoadjuvant chemoradiotherapy (NACRT) for pancreatic cancer and the incidence of IA following PD has not been evaluated. This study aims to identify the risk factors associated with IA that develops early after PD for pancreatic cancer. We retrospectively identified 94 patients who underwent PD for pancreatic cancer at the Department of General
Like
Comment
Share
